PROVIDENCE, RHODE ISLAND.
Trans Am Clin Climatol Assoc. 2022;132:224-235.
Cigarette smoking (CS) remains a cause of considerable morbidity and mortality, despite recent progress in smoking cessation in the United States. Epidemiologic studies in humans have reported associations between CS and development of acute respiratory distress syndrome (ARDS) after a number of inciting risk factors. We have assessed the effects of CS exposure on lung vascular permeability and inflammation in mice and found that both acute and sustained CS exposure increased the severity of acute lung injury caused by subsequent intrapulmonary instillation of lipopolysaccharide. In addition to enhanced inflammation, CS exposure directly impaired lung endothelial cell barrier function. Our results indicate that mouse strains differ in susceptibility to CS exacerbation of acute lung injury and that there are differences in transcriptomic effects of CS. These results demonstrate the biologic basis for the association of CS with development of ARDS. We propose that CS be considered a cause of heterogeneity of ARDS phenotypes and that this be recorded as a risk factor in the design of clinical trials.
尽管美国在戒烟方面取得了近期进展,但吸烟(CS)仍然是导致相当多发病率和死亡率的原因。流行病学研究在人类中报告了 CS 与许多引发风险因素后急性呼吸窘迫综合征(ARDS)发展之间的关联。我们评估了 CS 暴露对小鼠肺血管通透性和炎症的影响,发现急性和持续的 CS 暴露增加了随后肺内注入脂多糖引起的急性肺损伤的严重程度。除了增强炎症外,CS 暴露还直接损害了肺内皮细胞的屏障功能。我们的结果表明,小鼠品系对 CS 加重急性肺损伤的易感性不同,CS 的转录组效应也存在差异。这些结果表明 CS 与 ARDS 发展之间存在关联的生物学基础。我们提出将 CS 视为 ARDS 表型异质性的原因,并在临床试验设计中将其记录为危险因素。